Sensome today announced positive results from two studies of its Clotlid smart guidewire system for identifying blood clots. Outcomes highlighted Clotlid's ability to successfully identify "fresh" clot — thrombus rich in red blood cells (RBCs) — in peripheral artery disease (PAD) and differentiate it from other tissue encountered during PAD … [Read more...] about Sensome data supports clot-sensing guidewire
Research & Development
JenaValve to begin Trilogy heart valve trial
JenaValve announced today that it received the green light to begin a new randomized controlled trial for its Trilogy device. Irvine, California-based JenaValve can now start the ARTIST trial, slated for early next year. The company — set to be acquired by Edwards as part of a $1.2 billion double M&A swoop alongside Endotronix — also … [Read more...] about JenaValve to begin Trilogy heart valve trial
Boston Scientific resumes study of pulse field ablation as first-line AFib therapy
Boston Scientific (NYSE: BSX) is resuming its “Avant Guard” study of pulse field ablation as a first-line therapy for persistent atrial fibrillation (AFib). The device developer paused the trial last month, with CEO Mike Mahoney citing the need to “assess a few unanticipated observations.” Boston Scientific said it did not halt the trial due to … [Read more...] about Boston Scientific resumes study of pulse field ablation as first-line AFib therapy
This medtech developer is throwing everything at clots
Retriever Medical is developing a thrombectomy system with a four-front approach for treating blood clots. The Las Vegas-based startup calls its technology VORS AMD, for vascular occlusion removal system with aspiration, mechanical and drug delivery. The approach combines nitinol baskets for mechanical thrombectomy with aspiration, clot-busting … [Read more...] about This medtech developer is throwing everything at clots
First look: Medtronic’s Sphere-360 pulsed field ablation catheter design has some new tricks
The investigational Medtronic Sphere-360 pulsed field ablation and mapping catheter uses nitinol for a feature that's unique within Medtronic's PFA device portfolio.
Medtronic recently offered a first look at its Sphere-360 pulsed field ablation (PFA) and mapping catheter, an investigational device with some design features that are new for the world's largest device manufacturer.
In an interview with Medical Design & Outsourcing, Tim Laske, VP of research and business development for Medtronic Cardiac … [Read more...] about First look: Medtronic’s Sphere-360 pulsed field ablation catheter design has some new tricks The investigational Medtronic Sphere-360 pulsed field ablation and mapping catheter uses nitinol for a feature that's unique within Medtronic's PFA device portfolio.
How Abbott created its next-gen RF ablation system
For Abbott, combining two innovations into one AFib-treating system required manufacturing fine-tuning. The project’s R&D director explains. Pulsed field ablation (PFA) has generated a great deal of buzz for its potential to reduce complications in procedures for treating atrial fibrillation (AFib). But even as Abbott is developing its Volt … [Read more...] about How Abbott created its next-gen RF ablation system
Microbot Medical expands U.S. operations to prep for first in-human clinical study
Microbot Medical, the developer of the Liberty endovascular robotic surgical system, is building on the momentum from the positive results of its good laboratory practices (GLP) pre-clinical study. The company is adding a clinical research associate to support its pending investigational device exemption, or IDE, submission to commence its … [Read more...] about Microbot Medical expands U.S. operations to prep for first in-human clinical study
AVS is developing a new method of intravascular lithotripsy
Amplitude Vascular Systems (AVS) is working on a new way to treat severely calcified arterial disease. The name of the company’s peripheral intravascular lithotripsy (IVL) system is Pulse. The Boston-based startup could start enrolling patients in an investigational device exemption (IDE) study as soon as next year. AVS Chief Operating … [Read more...] about AVS is developing a new method of intravascular lithotripsy
Two-armed surgical robot prototype targets pediatric brain tumors
Researchers say they've developed a surgical robot for removing brain tumors in children, and that it could also offer a less invasive, safer option for adult neurosurgery and other procedures. The trick is using hollow, nitinol robot arms to allow neurosurgeons to swap tools during a tumor resection procedure, said Pierre DuPont. He's the chief … [Read more...] about Two-armed surgical robot prototype targets pediatric brain tumors
The top catheter innovation news stories of 2023 — so far
The world of catheter innovation has already seen remarkable strides this year— with some of the most promising medtech delivered into the body via catheter-based procedures. Think of improved ablation for treating AFib, coronary intravascular lithotripsy to combat coronary artery disease, and more. Here, we've highlighted the top five … [Read more...] about The top catheter innovation news stories of 2023 — so far
